Results 131 to 140 of about 2,687 (162)
Some of the next articles are maybe not open access.
Role of the GRP/GRPR System in Regulating Brain Functions
ACS Chemical Neuroscience, 2023Re-examining the relationship between neuropeptide systems and neural circuits will help us to understand more intensively the critical role of neuropeptides in brain function as the neural circuits responsible for specific brain functions are gradually revealed.
Tiantian Zhao +5 more
openaire +2 more sources
Oligoproline-based ligands for GRPR
2021Data for "Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone"
openaire +1 more source
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
Seminars in Nuclear MedicineGastrin-Releasing Peptide Receptor (GRPR) represents a promising molecular target for radionuclide therapy (TRT) across a variety of malignancies due to its overexpression in several tumor types, including prostate, breast, lung, melanoma, cervix, neuroblastoma, head and neck, and colon cancers.
Aurélien Callaud +4 more
openaire +2 more sources
BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells
Journal of Molecular Neuroscience, 2009Medulloblastoma is the most common brain tumor of childhood. Emerging molecular targets in medulloblastoma include neurotrophin and neuropeptide receptors. In the present study, we have examined the influence of brain-derived neurotrophic factor (BDNF)/TrkB receptor- and gastrin-releasing peptide receptor (GRPR)-mediated signaling on the viability of ...
Anna Laura, Schmidt +6 more
openaire +2 more sources
Targeting GRPR in urological cancers—from basic research to clinical application
Nature Reviews Urology, 2013Gastrin releasing peptide (GRP) is a regulatory peptide that acts through its receptor (GRPR) to regulate physiological functions in various organs. GRPR is overexpressed in neoplastic cells of most prostate cancers and some renal cell cancers and in the tumoral vessels of urinary tract cancers.
Mansi, Rosalba +3 more
openaire +4 more sources
425 GRPR is an effective target for melanoma
Journal of Investigative Dermatology, 2022J. Raymond +5 more
openaire +1 more source
ESDR425 - GRPR is an effective target for melanoma
2022Veronique Delmas +5 more
openaire +1 more source
Bioorthogonal chemistry approach for theranostics of GRPR-expressing cancers
Nuclear Medicine and Biology, 2022Lurdes Gano +8 more
openaire +1 more source

